REPORT SCOPE & OVERVIEW
The Microcarriers Market size was estimated USD 1.4 billion in 2022 and is expected to reach USD 3.39 billion by 2030 at a CAGR of 11.7% during the forecast period of 2023-2030.
Microcarriers operate as a support matrix for adherent cell growth. These microcarriers are used in a bioreactor to help in cell proliferation. Pharmaceutical businesses and research institutes are increasingly relying on microcarrier dry powder and related equipment to conduct rigorous R&D operations. The growing global disease burden has increased R&D activity in order to provide therapeutically effective drugs/vaccines, resulting in a demand for microcarrier goods.
MARKET DYNAMICS
DRIVERS
Growing interest in cell-based vaccines
Population expansion, climate change, and more human-animal contact have all increased the risk of new viral epidemics. For example, influenza and COVID-19 have shown to be unpredictable and recurring phenomena that impose a large economic and social burden. The WHO reported 117.33 million cases of COVID-19 worldwide as of March 10, 2021, including 2.61 million deaths. The rising prevalence of infectious diseases, as well as the growing threat of pandemics, are predicted to drive global vaccination demand.
RESTRAIN
Cell biology research is expensive
Cell biology entails a significant amount of research and development (R&D) on new medicines such as stem cell and gene therapies. The equipment, media, reagents, and other products associated with research must be of the highest quality to provide accurate results The cost of cell biology research has risen significantly as a result of the growing necessity to maintain high quality standards (by the use of high-grade materials) and comply with regulatory body norms. As a result, with inadequate funding, many academic institutions and small firms are unable to pursue cell biology research. Because microcarriers are used in stem cell biology, this factor is likely to limit market expansion. Moreover, because microcarriers adhere to cells, the cells must be collected, which increases downstream processing costs. As a result, the expansion of the microcarrier market is projected to be limited.
OPPORTUNITY
Increasing monoclonal antibody synthesis is increasing.
The increased popularity of targeted treatment options for diseases such as cancer, autoimmune and inflammatory illnesses is driving up demand for monoclonal antibodies internationally. Because antibodies are given in high concentrations, the need for mAbs is also significant.
CHALLENGES
The unavailability of low-cost serum-free media, as well as microcarrier-cell detachment
IMPACT OF RUSSIAN UKRAINE WAR
Although the Russian pharmaceutical industry was not subject to Western sanctions imposed following the invasion of Ukraine, domestic players experienced significant difficulties in importing active ingredients. According to the local analyst firm RNC Pharma, Russian medicine makers rely on imported raw ingredients to the tune of 80%. China and India account for more than two-thirds of all imports. Moreover, while these countries continue to serve the Russian Federation, supply systems in these areas have also failed.
IMPACT OF ONGOING RECESSION
The global pandemic of the new coronavirus (COVID-19) caused tremendous volatility, uncertainty, and economic disruption in several of the nations where we operate, including the United States, Mexico, Canada, Poland, Germany, Hungary, and China. We believe the pandemic impacted customer demand for our products as well as customer preferences regarding product mix and distribution channels, and there is significant uncertainty regarding general economic conditions as we emerge from the pandemic, including rising inflation, supply chain disruptions, and a possible national or global recession.
KEY SEGMENTS
By Consumable
Media & Reagents
Microcarrier Bead
Collagen Coated Beads
Cationic Beads
Protein Coated Beads
Untreated Beads
Others
In 2022, microcarrier bead segment is expected to held the highest market share of 65.2% during the forecast period due to the constant development of microcarrier beads during cell culture adds to the market's highest revenue generating. Increased cell biology research, rising demand for regenerative therapies and biopharmaceuticals, and the availability of a variety of microcarrier beads that can be used for a variety of reasons have all contributed to the significant market expansion.
By Application
Biopharmaceutical Production
Vaccine Production
Therapeutic Production
Regenerative Medicine
In 2022, the biopharmaceutical Production segment is expected to dominate the market growth of 73.8% during the forecast period Because of the rising frequency of cancer, infectious diseases, and genetic problems, there is a greater need for safe and effective medicines and therapies. Biopharmaceutical businesses are expanding their capacity and product offerings to satisfy rising demand. For instance, in August 2022, Celltrion Inc., a Korea-based healthcare business, announced that its bevacizumab biosimilar, Vegzelma, has been approved by the European Commission for the treatment of certain forms of cancer. With the approval of its third biosimilar, the business has expanded its oncology treatment range for usage in Europe.
Furthermore, increased therapeutic biopharmaceutical usage and regulatory backing are driving the microcarriers market. For example, the US FDA has authorized 39 biosimilars till September 2022. These approvals have demonstrated that safe and effective biosimilars penetrated market and improved the access to care by offering multiple medication options at potentially lower costs.
By End User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations & Contract Manufacturing Organizations
Academic & Research Institutes
.png)
In 2022, the pharmaceutical & biotechnology companies & CROs segment is expected to dominate the market growth of 73.8% during the forecast period to due to multiple drug research initiatives, the rising cell therapy business, greater R&D investments, and favorable government laws are all driving the expansion of this market. Furthermore, increased knowledge of the benefits of cell-based products is pushing biologics manufacturing by these enterprises, resulting in global development of capabilities. For example, Thermo Fisher Scientific, Inc. announced in August 2022 that it had enlarged its facility in Grand Island, New York. The USD 77 million expansion boosts the company's capacity to generate cell culture media for the production of vaccines and biologics.
REGIONAL ANALYSES
North America held a significant market share of over 41.8% in 2022 due to rising chronic and infectious illness cases, increased knowledge of personalized medicines, improved healthcare infrastructure and reimbursement models, the presence of important market participants, and intensive R&D activities have all contributed to the region's rise. Furthermore, regulatory support for biopharmaceuticals and regenerative medicines is propelling innovative cell-based therapeutics to market. Because of current clinical success rates and the product pipeline, the US FDA forecasts that by 2025, it will be approving 10 to 20 cell and gene therapy items per year.
Asia-Pacific is witness to expand fastest CAGR rate during the forecast period owing to multiple research settings in the region are driven by government funds for vaccine manufacturing and low operating and labor expenses. Furthermore, the Asia Pacific area is driven by domestic biologics demand as well as expanding economies, and it also has the greatest elderly population. Furthermore, in this region, numerous local Asian and international corporations are establishing a number of the world's new bioprocessing facilities.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Key Players
The major key players are Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Sartorius AG, Corning Incorporated, Medtronic, Bio-Rad Laboratories, Inc., HiMedia Laboratories Pvt. Ltd., denovoMATRIX GmbH, Fujitsu Ltd., Microcarrier Corporation, Qualcomm, and Others.
RECENT DEVELOPMENT
denovoMATRIX GmbH, in May 2022 denovoMATRIX GmbH, a cell and gene therapy manufacturing firm based in Germany, has launched a new product called beadMATRIX. The new product is a unique microcarrier bead for 3D MSC culture that allows for high-quality and rapid stem cell proliferation.
Microcarrier Corporation, in february 2022, Microcarrier Corporation and Fujitsu Ltd. announced the signing of a formal agreement in which Fujitsu will purchase Microcarrier. The acquisition is estimated to be worth $4.2 billion.
In April 2022, Microcarrier Corporation and IBM signed a formal deal under which IBM will acquire Microcarrier for $4.4 billion.
In June 2022, Qualcomm and Microcarrier Corporation signed a definitive deal for Qualcomm to acquire Microcarrier for $4.5 billion.
| Report Attributes | Details |
| Market Size in 2022 | US$ 1.4 Billion |
| Market Size by 2030 | US$ 3.39 Billion |
| CAGR | CAGR of 11.7 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Consumables (Media & Reagents, Microcarrier Beads) • By Application (Biopharmaceutical Production, Regenerative Medicine) • By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Sartorius AG, Corning Incorporated, Medtronic, Bio-Rad Laboratories, Inc., HiMedia Laboratories Pvt. Ltd., denovoMATRIX GmbH, Fujitsu Ltd., Microcarrier Corporation, Qualcomm |
| Key Drivers | • Growing interest in cell-based vaccines |
| Market Challenges | • The unavailability of low-cost serum-free media, as well as microcarrier-cell detachment |
Ans: Microcarrier beads segment dominated the microcarriers market with a share of 65.2% in 2022.
Ans: Microcarriers Market is anticipated to expand by 11.7% from 2023 to 2030.
Ans: The growth rate of microcarriers market is expected to grow USD 1.4 billion by 2030.
Ans: Microcarriers Market size was valued at USD 3.39 billion in 2022.
Ans: Growing interest in cell-based vaccines.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Microcarriers Market Segmentation, By Consumables
8.1 Media & Reagents
8.2 Microcarrier Beads
8.2.1 Collagen Coated Beads
8.2.2 Cationic Beads
8.2.3 Protein Coated Beads
8.2.4 Untreated Beads
8.2.5 Others
9. Microcarriers Market Segmentation, By Application
9.1 Biopharmaceutical Consumablesion
9.1.1 Vaccine Consumablesion
9.1.2 Therapeutic Consumablesion
9.2 Regenerative Medicine
10. Microcarriers Market Segmentation, By End User
10.1 Pharmaceutical & Biotechnology Companies
10.2 Contract Research Organizations & Contract Manufacturing Organizations
10.3 Academic & Research Institutes
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Microcarriers Market by Country
11.2.2 North America Microcarriers Market by Consumables
11.2.3 North America Microcarriers Market by Application
11.2.4 North America Microcarriers Market by End User
11.2.5 USA
11.2.5.1 USA Microcarriers Market by Consumables
11.2.5.2 USA Microcarriers Market by Application
11.2.5.3 USA Microcarriers Market by End User
11.2.6 Canada
11.2.6.1 Canada Microcarriers Market by Consumables
11.2.6.2 Canada Microcarriers Market by Application
11.2.6.3 Canada Microcarriers Market by End User
11.2.7 Mexico
11.2.7.1 Mexico Microcarriers Market by Consumables
11.2.7.2 Mexico Microcarriers Market by Application
11.2.7.3 Mexico Microcarriers Market by End User
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Microcarriers Market by Country
11.3.1.2 Eastern Europe Microcarriers Market by Consumables
11.3.1.3 Eastern Europe Microcarriers Market by Application
11.3.1.4 Eastern Europe Microcarriers Market by End User
11.3.1.5 Poland
11.3.1.5.1 Poland Microcarriers Market by Consumables
11.3.1.5.2 Poland Microcarriers Market by Application
11.3.1.5.3 Poland Microcarriers Market by End User
11.3.1.6 Romania
11.3.1.6.1 Romania Microcarriers Market by Consumables
11.3.1.6.2 Romania Microcarriers Market by Application
11.3.1.6.4 Romania Microcarriers Market by End User
11.3.1.7 Turkey
11.3.1.7.1 Turkey Microcarriers Market by Consumables
11.3.1.7.2 Turkey Microcarriers Market by Application
11.3.1.7.3 Turkey Microcarriers Market by End User
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Microcarriers Market by Consumables
11.3.1.8.2 Rest of Eastern Europe Microcarriers Market by Application
11.3.1.8.3 Rest of Eastern Europe Microcarriers Market by End User
11.3.2 Western Europe
11.3.2.1 Western Europe Microcarriers Market by Consumables
11.3.2.2 Western Europe Microcarriers Market by Application
11.3.2.3 Western Europe Microcarriers Market by End User
11.3.2.4 Germany
11.3.2.4.1 Germany Microcarriers Market by Consumables
11.3.2.4.2 Germany Microcarriers Market by Application
11.3.2.4.3 Germany Microcarriers Market by End User
11.3.2.5 France
11.3.2.5.1 France Microcarriers Market by Consumables
11.3.2.5.2 France Microcarriers Market by Application
11.3.2.5.3 France Microcarriers Market by End User
11.3.2.6 UK
11.3.2.6.1 UK Microcarriers Market by Consumables
11.3.2.6.2 UK Microcarriers Market by Application
11.3.2.6.3 UK Microcarriers Market by End User
11.3.2.7 Italy
11.3.2.7.1 Italy Microcarriers Market by Consumables
11.3.2.7.2 Italy Microcarriers Market by Application
11.3.2.7.3 Italy Microcarriers Market by End User
11.3.2.8 Spain
11.3.2.8.1 Spain Microcarriers Market by Consumables
11.3.2.8.2 Spain Microcarriers Market by Application
11.3.2.8.3 Spain Microcarriers Market by End User
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Microcarriers Market by Consumables
11.3.2.9.2 Netherlands Microcarriers Market by Application
11.3.2.9.3 Netherlands Microcarriers Market by End User
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Microcarriers Market by Consumables
11.3.2.10.2 Switzerland Microcarriers Market by Application
11.3.2.10.3 Switzerland Microcarriers Market by End User
11.3.2.11.1 Austria
11.3.2.11.2 Austria Microcarriers Market by Consumables
11.3.2.11.3 Austria Microcarriers Market by Application
11.3.2.11.4 Austria Microcarriers Market by End User
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Microcarriers Market by Consumables
11.3.2.12.2 Rest of Western Europe Microcarriers Market by Application
11.3.2.12.3 Rest of Western Europe Microcarriers Market by End User
11.4 Asia-Pacific
11.4.1 Asia-Pacific Microcarriers Market by Country
11.4.2 Asia-Pacific Microcarriers Market by Consumables
11.4.3 Asia-Pacific Microcarriers Market by Application
11.4.4 Asia-Pacific Microcarriers Market by End User
11.4.5 China
11.4.5.1 China Microcarriers Market by Consumables
11.4.5.2 China Microcarriers Market by End User
11.4.5.3 China Microcarriers Market by Application
11.4.6 India
11.4.6.1 India Microcarriers Market by Consumables
11.4.6.2 India Microcarriers Market by Application
11.4.6.3 India Microcarriers Market by End User
11.4.7 Japan
11.4.7.1 Japan Microcarriers Market by Consumables
11.4.7.2 Japan Microcarriers Market by Application
11.4.7.3 Japan Microcarriers Market by End User
11.4.8 South Korea
11.4.8.1 South Korea Microcarriers Market by Consumables
11.4.8.2 South Korea Microcarriers Market by Application
11.4.8.3 South Korea Microcarriers Market by End User
11.4.9 Vietnam
11.4.9.1 Vietnam Microcarriers Market by Consumables
11.4.9.2 Vietnam Microcarriers Market by Application
11.4.9.3 Vietnam Microcarriers Market by End User
11.4.10 Singapore
11.4.10.1 Singapore Microcarriers Market by Consumables
11.4.10.2 Singapore Microcarriers Market by Application
11.4.10.3 Singapore Microcarriers Market by End User
11.4.11 Australia
11.4.11.1 Australia Microcarriers Market by Consumables
11.4.11.2 Australia Microcarriers Market by Application
11.4.11.3 Australia Microcarriers Market by End User
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Microcarriers Market by Consumables
11.4.12.2 Rest of Asia-Pacific Microcarriers Market by Application
11.4.12.3 Rest of Asia-Pacific Microcarriers Market by End User
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Microcarriers Market by Country
11.5.1.2 Middle East Microcarriers Market by Consumables
11.5.1.3 Middle East Microcarriers Market by Application
11.5.1.4 Middle East Microcarriers Market by End User
11.5.1.5 UAE
11.5.1.5.1 UAE Microcarriers Market by Consumables
11.5.1.5.2 UAE Microcarriers Market by Application
11.5.1.5.3 UAE Microcarriers Market by End User
11.5.1.6 Egypt
11.5.1.6.1 Egypt Microcarriers Market by Consumables
11.5.1.6.2 Egypt Microcarriers Market by Application
11.5.1.6.3 Egypt Microcarriers Market by End User
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Microcarriers Market by Consumables
11.5.1.7.2 Saudi Arabia Microcarriers Market by Application
11.5.1.7.3 Saudi Arabia Microcarriers Market by End User
11.5.1.8 Qatar
11.5.1.8.1 Qatar Microcarriers Market by Consumables
11.5.1.8.2 Qatar Microcarriers Market by Application
11.5.1.8.3 Qatar Microcarriers Market by End User
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Microcarriers Market by Consumables
11.5.1.9.2 Rest of Middle East Microcarriers Market by Application
11.5.1.9.3 Rest of Middle East Microcarriers Market by End User
11.5.2 Africa
11.5.2.1 Africa Microcarriers Market by Country
11.5.2.2 Africa Microcarriers Market by Consumables
11.5.2.3 Africa Microcarriers Market by Application
11.5.2.4 Africa Microcarriers Market by End User
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Microcarriers Market by Consumables
11.5.2.5.2 Nigeria Microcarriers Market by Application
11.5.2.5.3 Nigeria Microcarriers Market by End User
11.5.2.6 South Africa
11.5.2.6.1 South Africa Microcarriers Market by Consumables
11.5.2.6.2 South Africa Microcarriers Market by Application
11.5.2.6.3 South Africa Microcarriers Market by End User
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Microcarriers Market by Consumables
11.5.2.7.2 Rest of Africa Microcarriers Market by Application
11.5.2.7.3 Rest of Africa Microcarriers Market by End User
11.6 Latin America
11.6.1 Latin America Microcarriers Market by Country
11.6.2 Latin America Microcarriers Market by Consumables
11.6.3 Latin America Microcarriers Market by Application
11.6.4 Latin America Microcarriers Market by End User
11.6.5 Brazil
11.6.5.1 Brazil Microcarriers Market by Consumables
11.6.5.2 Brazil Microcarriers Market by Application
11.6.5.3 Brazil Microcarriers Market by End User
11.6.6 Argentina
11.6.6.1 Argentina Microcarriers Market by Consumables
11.6.6.2 Argentina Microcarriers Market by Application
11.6.6.3 Argentina Microcarriers Market by End User
11.6.7 Colombia
11.6.7.1 Colombia Microcarriers Market by Consumables
11.6.7.2 Colombia Microcarriers Market by Application
11.6.7.3 Colombia Microcarriers Market by End User
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Microcarriers Market by Consumables
11.6.8.2 Rest of Latin America Microcarriers Market by Application
11.6.8.3 Rest of Latin America Microcarriers Market by End User
12. Company profile
12.1 Thermo Fisher Scientific, Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Product / Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Merck KGaA
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Danaher Corporation
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Sartorius AG
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Corning Incorporated
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Medtronic
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Bio-Rad Laboratories Inc.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 HiMedia Laboratories Pvt. Ltd.
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 denovoMATRIX GmbH
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Fujitsu Ltd.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 Microcarrier Corporation
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Product/Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.11 Microcarrier Corporation
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Product/Services Offered
12.12.4 SWOT Analysis
12.12.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Healthcare Virtual Assistants Market size was valued at USD 957.61 million in 2022 and is projected to reach USD 10.44 billion with a growing CAGR of 34.8% over the forecast period 2023-2030.
The Point of Care Diagnostics/Testing Market Size was valued at USD 23.99 billion in 2022 and is expected to reach USD 58.97 billion by 2030, and grow at a CAGR of 11.9% over the forecast period 2023-2030.
The Autoinjectors Market size was estimated USD 0.8 billion in 2022 and is expected to reach USD 2.3 billion by 2030 at a CAGR of 14.2% during the forecast period of 2023-2030.
The Internet of Things in Healthcare Market Size was valued at USD 100.41 billion in 2022, and is expected to reach USD 467.51 billion by 2030 and grow at a CAGR of 21.2% over the forecast period 2023-2030.
The Life Science Tools Market size was estimated USD 145.01 billion in 2022 and is expected to reach USD 331.7 billion by 2030 at a CAGR of 10.9% during the forecast period of 2023-2030.
The AI in Cancer Diagnosis market was valued at USD 118.54 billion in 2022 and is expected to reach at USD 845.78 billion by 2030 and grow at a CAGR of 27.8% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2023 All Rights Reserved by SNS Insider Pvt Ltd
